Tenaya Therapeutics Inc (NASDAQ: TNYA) on Monday, soared 24.23% from the previous trading day, before settling in for the closing price of $1.94. Within the past 52 weeks, TNYA’s price has moved between $1.61 and $7.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 11.24%. With a float of $65.30 million, this company’s outstanding shares have now reached $68.33 million.
Let’s look at the performance matrix of the company that is accounted for 140 employees. In terms of profitability, gross margin is 42.02%, operating margin of -718.7%, and the pretax margin is -683.52%.
Tenaya Therapeutics Inc (TNYA) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Tenaya Therapeutics Inc is 17.22%, while institutional ownership is 57.22%. The most recent insider transaction that took place on Aug 16 ’24, was worth 6,840. In this transaction SVP, Accounting and Fin. Ops. of this company sold 2,363 shares at a rate of $2.89, taking the stock ownership to the 63,241 shares. Before that another transaction happened on Aug 16 ’24, when Company’s Chief Medical Officer sold 7,428 for $2.89, making the entire transaction worth $21,500. This insider now owns 107,106 shares in total.
Tenaya Therapeutics Inc (TNYA) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 11.24% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
Tenaya Therapeutics Inc (TNYA) is currently performing well based on its current performance indicators. A quick ratio of 6.28 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.57, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.56 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Tenaya Therapeutics Inc (NASDAQ: TNYA) saw its 5-day average volume 7.84 million, a positive change from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 40.97%. Additionally, its Average True Range was 0.22.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 32.65%, which indicates a significant decrease from 67.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 138.55% in the past 14 days, which was higher than the 95.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0700, while its 200-day Moving Average is $3.7000. Nevertheless, the first resistance level for the watch stands at $2.7200 in the near term. At $3.0200, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.3000. If the price goes on to break the first support level at $2.1400, it is likely to go to the next support level at $1.8600. Assuming the price breaks the second support level, the third support level stands at $1.5600.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
Market capitalization of the company is 192.10 million based on 78,889K outstanding shares. Right now, sales total 0 K and income totals -124,080 K. The company made 0 K in profit during its latest quarter, and -29,430 K in sales during its previous quarter.
